We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Presentation to Outline Innovative Methodology for Developing Indication-Specific Outcome Measures in Rare Disease Clinical Trials The cognitive science company, Cogstate Ltd (ASX:CGS...
Le spécialiste des sciences cognitives Cogstate a annoncé aujourd’hui que sa division Soins de santé (Healthcare) a obtenu l’autorisation de marquage CE pour son système numérique...
Announcing LifeSpring Physiotherapy as Latest Customer The cognitive science company, Cogstate, today announced that its Healthcare Division recently received Health Canada marketing...
Siemers will provide expert advice for Cogstate in neurodegeneration research The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the appointment of Eric Siemers, M.D...
From the Interdisciplinary Conference on Orthopedic Value Based Care sponsored by the American College of Perioperative Medicine, Cogstate announced that the Cogstate Brief BatteryTM has now...
The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the addition of Dr. Chris Edgar, Senior Vice President, Clinical Science to its global scientific leadership team. Dr...
Cogstate to Support Rater Training and Certification Program to Enable Accelerated Study Start-up in Alzheimer’s Disease Clinical Trials The cognitive science company, Cogstate Ltd...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.025 | 2.5641025641 | 0.975 | 1.005 | 0.95 | 84843 | 0.96102165 | DE |
4 | 0.035 | 3.62694300518 | 0.965 | 1.005 | 0.95 | 84706 | 0.97246654 | DE |
12 | 0.13 | 14.9425287356 | 0.87 | 1.06 | 0.795 | 145092 | 0.92499521 | DE |
26 | -0.235 | -19.028340081 | 1.235 | 1.265 | 0.795 | 172710 | 1.01391649 | DE |
52 | -0.49 | -32.8859060403 | 1.49 | 1.51 | 0.795 | 142537 | 1.12596568 | DE |
156 | -1.12 | -52.8301886792 | 2.12 | 2.68 | 0.795 | 201520 | 1.62445184 | DE |
260 | 0.65 | 185.714285714 | 0.35 | 2.68 | 0.29 | 186630 | 1.48949756 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions